Initial treatment trends in patient with osteoporosis: Use of antiresorptive agents and pharmacologic supplements (calcium and vitamin D) in clinical practice;Pauta de tratamiento inicial en pacientes con osteoporosis: uso de antirresortivos y suplementos farmacológicos (calcio y vitamina D) en la práctica clínica

Reumatologia Clinica

Volumn 8, Issue 1, 2012, Pages 3-9

  Carbonell, Cristina ^a   Díez, Adolfo ^b   Calaf, Joaquín ^c   Caloto, María Teresa ^d   Nocea, Gonzalo ^d   Lara, Nuria ^e  

^a Centro de Salud Vía Roma ^*  (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d Medical affairs Merck sharp and Dohme ltd   (Spain)

^e IQVIA   (United States)

Author keywords

Calcium supplementation; Drug prescriptions; Medical specialties; Vitamin D supplementation

Indexed keywords

BONE DENSITY CONSERVATION AGENT; CALCIUM; VITAMIN D;

ARTICLE; CLINICAL PRACTICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; OSTEOPOROSIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; TREND STUDY;

AGED; BONE DENSITY CONSERVATION AGENTS; CALCIUM; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; RETROSPECTIVE STUDIES; VITAMIN D;

EID: 84856240396     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2011.07.006     Document Type: Article

References (27)

1. Osteoporosis postmenopáusica Guía de práctica clínica. Grupo de trabajo de la Sociedad Española de Investigaciones óseas y Metabolismo Mineral (SEIOMM). Rev Clin Esp 2003, 203:496-506.
2. Diaz Curiel M., Garcia J.J., Carrasco J.L., Honorato J., Perez Cano R., Rapado A., et al. Prevalence of osteoporosis assessed by densitometry in the Spanish female population. Med Clin (Barc) 2001, 116:86-88.
3. Reyes Balaguer J., Moreno Olmos J. Prevalence of osteopenia and osteoporosis in postmenopausal women. Aten Primaria 2005, 35:342-345.
4. Herrera A., Martínez A.A., Fernández L., Gil E., Moreno A. Epidemiology of osteoporotic hip fractures in Spain. Int Orthop 2006, 30:11-14.
5. Moreno Girao M., Centelles Manosa F., Jovell Fernandez E. Indication of bone densitometry in women over 40 years of age. Aten Primaria 2005, 35:253-257.
6. Reginster J.Y., Burlet N. Osteoporosis: a still increasing prevalence. Bone 2006, 38:S4-S9.
7. Bouza C., López T., Palma M., Amate J.M. Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry. Osteoporos Int 2007, 18:649-657.
8. González Macías J., Guañabens Gay N., Gómez Alonso C., Del Río Barquero L., Muñoz Torres M., Delgado M., et al. Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad española de investigación ósea y del metabolismo mineral. Rev Clin Esp 2008, 208(Suppl 1):1-24. Comité de Redacción, en representación del Comité de Expertos de la SEIOMM para la elaboración de las Guías.
9. Riggs B.L., O'Fallon W.M., Muhs J., O'Cconor M.K., Kumar R., Melton L.J. Long-term effect of calcium supplementation on serum parathyroid hormeno level, bone turnover and bone loss in elderly women. J bone Miner Res 1998, 13:168-174.
10. Holick M.F. The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep 2006, 4:96-102.
11. Bischoff-Ferrari H.A., Staehelin H.B. Importante of vitamin D and calcium at older age. Int J Vital Nutr Res 2008, 78:286-292.
12. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly:consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001, 22:477-501.
13. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-716.
14. Van der Wielen R.P.J., De Groot L.C.P.G.M., Van Staveren W.A., Löwik M.R.H., Van den Berg H., Haller J., et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995, 346:207-210.
15. National Osteoporosis Foundation. Scientific statement Updated recommendations for calcium and Vitamin D intake [consultado 18 Nov 2007]. Disponible en: http://www.nof.org/prevention/calcium_and_vitamin%20D.htm.
16. Jackson R.D., LaCroix A.Z., Gass M., Wallace R.B., Robbins J., Lewis C.E., et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354:669-683.
17. Grant A.M., Avenell A., Campbell M.K., McDonald A.M., MacLennan G.S., McPherson G.C., et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomised Evaluation of Calcium Or vitamin D RECORD: A randomised placebo-controlled trial. Lancet 2005, 365:1621-1628.
18. Porthouse J., Cockayne S., King C., Saxon L., Steele E., Aspray T., et al. Randomised controlled trial of calcium and supplementation with cholecalciferon (vitamin D3) for prevention of fractures in primary care. BMJ 2005, 330:1003.
19. Nguyen T.V., Center J.R., Eximan J.A. Osteoporosis: underrated, underdiagnosed and undertreated. MJA 2004, 180(5 Suppl):S18-S22.
20. Hall L.N., Shrader S.P., Ragucci K.R. Evaluation of compliance with osteoporosis treatment guidelines alter initiation of a pharmacist-run osteoporosis service at a family medicine clinic. Ann Pharmacother 2009, 43:1781-1786.
21. Zwart Salmerón M., Fradera Vilalta M., Solanas Saura P., González Pastor C., Adalid Vilar C. Abordaje de la osteoporosis en un centro de atención primaria. Aten Primaria 2004, 33:183-187.
22. Saag K.G., Geusen P. Progress in osteoporosis and fracture prevention. Focus on postmenopausal women. Arthritis Res Ther 2009, 11:251.
23. Lewiedki E.M. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis. J Womens Health 2009, 18:1615-1626.
24. ESCEO (The european society for clinical and economic aspects of osteoporosis and osteoarthritis). Guía Europea para el diagnóstico y tratamiento de la osteoporosis en la mujer postmenopáusica [consultado 12 Ago 2009]. Disponible en: http://www.iofbonehealth.org/download/osteofound/filemanager/health_professionals/pdf/endorsed-papers/pocket-esceo-spanish.pdf.
25. Erviti J. Utilización de fármacos para la osteoporosis. An Sist Sanit Nav 2003, 26(Supl 3):107-121.
26. Aguado P., Garcés M.V., González Casaús M.L., Del Campo M.T., Richi P., Coya J., et al. High prevalence of vitamina D deficiency in postmenopausal women at a rheumatology office in Madrid. Evaluation of 2 vitamin D preception regimens. Med Clin (Barc) 2000, 114:326-330.
27. Gill J.M., Hoffman M.K. Prevention and treatment of osteoporosis in primary care offices. J Womens Health 2003, 12:473-480.